Rana Rais, Ph.D.
Affiliations: | 2010 | Pharmaceutical Sciences | University of Maryland School of Medicine, Baltimore, MD, United States |
Area:
PharmacyGoogle:
"Rana Rais"Parents
Sign in to add mentorJames E. Polli | grad student | 2010 | University of Maryland Medical School | |
(Delineating structural requirements of hASBT: A rational approach to prodrug design.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Duvall B, Zimmermann SC, Gao RD, et al. (2020) Allosteric kidney-type glutaminase (GLS) inhibitors with a mercaptoethyl linker. Bioorganic & Medicinal Chemistry. 28: 115698 |
Giancola JB, Bonifazi A, Cao J, et al. (2020) Structure-activity relationships for a series of (Bis(4-fluorophenyl)methyl)sulfinylethyl-aminopiperidines and -piperidine amines at the dopamine transporter: Bioisosteric replacement of the piperazine improves metabolic stability. European Journal of Medicinal Chemistry. 208: 112674 |
Khoury ES, Sharma A, Ramireddy RR, et al. (2020) Dendrimer-conjugated glutaminase inhibitor selectively targets microglial glutaminase in a mouse model of Rett syndrome. Theranostics. 10: 5736-5748 |
Oh MH, Sun IH, Zhao L, et al. (2020) Targeting glutamine metabolism enhances tumor specific immunity by modulating suppressive myeloid cells. The Journal of Clinical Investigation |
Sala M, Hollinger KR, Thomas AG, et al. (2020) Novel human neutral sphingomyelinase 2 inhibitors as potential therapeutics for Alzheimer disease. Journal of Medicinal Chemistry |
Powell J, Leone R, Oh M, et al. (2020) Abstract IA10: Targeting glutamine metabolism as a means of enhancing immunotherapy for cancer Clinical Cancer Research. 26 |
Leone RD, Zhao L, Englert JM, et al. (2019) Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science (New York, N.Y.) |
Slack RD, Ku T, Cao J, et al. (2019) Structure-Activity Relationships for a series of bis(4-fluorophenyl)methyl)sulfinyl)alkyl alicyclic amines at the dopamine transporter: functionalizing the terminal nitrogen affects affinity, selectivity and metabolic stability. Journal of Medicinal Chemistry |
Lemberg KM, Zhao L, Wu Y, et al. (2019) The novel glutamine antagonist prodrug JHU395 has antitumor activity in malignant peripheral nerve sheath tumor. Molecular Cancer Therapeutics |
Shaik AB, Kumar V, Bonifazi A, et al. (2019) Investigation of novel primary and secondary pharmacophores, and 3-substitution in the linking chain of a series of highly selective and bitopic dopamine D3 receptor antagonists and partial agonists. Journal of Medicinal Chemistry |